BIVALIRUDIN Side Effects

6382014-8 | Femoral Bruit, Haematoma, Vascular Pseudoaneurysm
on Sep 14, 2009 Male patient from UNITED STATES , 82 years of age, weighting 145.5 lb, was treated with Bivalirudin (View Usage). Patient experienced the following unwanted or unexpected effects: femoral bruit, haematoma, vascular pseudoaneurysm. Bivalirudin dosage: 50 Mg, Bolus, Intravenous; 115 Mg, Intravenous. During the same period patient was treated with CLOPIDOGREL (4 Pre-procedure Capsules, Single, Oral) (View Clopidogrel Review and Clopidogrel Label ), ASPIRIN (325 Mg, Qd, Oral) (View Aspirin Review and Aspirin Label ), HEPARIN (850 Ut, Hr, Intravenous) (View Heparin Review and Heparin Label ). Patient was hospitalized.

5721518-5 | Cough, Hypotension, Hypoxia, Wheezing
Patient was taking Bivalirudin (View Usage). Patient had the following side effects: cough, hypotension, hypoxia, wheezing on Apr 28, 2008 from UNITED STATES Additional patient health information: Male patient , 88 years of age, . Bivalirudin dosage: . During the same period patient was treated with CONTRAST (View Contrast Review and Contrast Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ). Patient was hospitalized.

5310291-0 | Bradycardia
Adverse event was reported on Apr 17, 2007 by a Male patient taking Bivalirudin (View Usage) (Dosage: Unk) was diagnosed with percutaneous coronary intervention and. Location: UNITED STATES , 75 years of age, weighting 191.8 lb, After Bivalirudin was administered, patient had the following side effects: bradycardia. During the same period patient was treated with PLAVIX (Four Capsules Prior To Pci And Four Capsules Post Pci) (View Plavix Review and Plavix Label ), FENTANYL (Unk) (View Fentanyl Review and Fentanyl Label ), MIDAZOLAM HCL (Unk) (View Midazolam Hcl Review and Midazolam Hcl Label ).

5206909-3 | Hypotension, Infusion Related Reaction, Loss Of Consciousness, Thrombosis
on Jan 05, 2007 Female patient from UNITED STATES , 70 years of age, weighting 141.5 lb, was treated with Bivalirudin (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, infusion related reaction, loss of consciousness, thrombosis. Bivalirudin dosage: 12.75mg Iv X 1; 29.75mg/hr. During the same period patient was treated with AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ).


4965801-X | Cardiac Arrest, Cardiac Failure, Coagulation Time Prolonged, Oxygen Saturation Decreased, Pulmonary Haemorrhage, Ventricular Fibrillation
on Apr 06, 2006 Female patient from UNITED STATES , 66 years of age, weighting 167.6 lb, was diagnosed with atrial thrombosis, deep vein thrombosis (What is deep vein thrombosis?), heparin-induced thrombocytopenia, pulmonary artery thrombosis, pulmonary embolism (What is pulmonary embolism?) and was treated with Bivalirudin (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), cardiac failure, coagulation time prolonged, oxygen saturation decreased, pulmonary haemorrhage, ventricular fibrillation. Bivalirudin dosage: See Image.

4867493-7 | Coronary Artery Thrombosis
Patient was taking Bivalirudin (View Usage). After Bivalirudin was administered, patient had the following side effects: coronary artery thrombosis on Dec 27, 2005 from UNITED STATES Additional patient health information: Male patient , 58 years of age, weighting 210.5 lb, was diagnosed with catheterisation cardiac and. Bivalirudin dosage: 71mg Bolus X1 Iv Bolus; 166mg/hr X30 Min Iv Drip.

4653245-X | Post Procedural Complication
Adverse event was reported on May 03, 2005 by a Female patient taking Bivalirudin (View Usage) (Dosage: Bolus-} 70 Mg Continuing 185 Mg/m2) was diagnosed with angioplasty (What is angioplasty?), chest pain (What is chest pain?) and. Location: , 85 years of age, Patient experienced the following unwanted or unexpected effects: post procedural complication. Patient was hospitalized.